These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23051949)

  • 21. Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failure.
    Charach G; Grosskopf I; Roth A; Afek A; Wexler D; Sheps D; Weintraub M; Rabinovich A; Keren G; George J
    Am J Cardiol; 2011 May; 107(9):1353-6. PubMed ID: 21371686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
    Mentz RJ; Schmidt PH; Kwasny MJ; Ambrosy AP; O'Connor CM; Konstam MA; Zannad F; Maggioni AP; Swedberg K; Gheorghiade M
    J Card Fail; 2012 Jul; 18(7):515-23. PubMed ID: 22748484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
    Konstam MA; Gheorghiade M; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
    JAMA; 2007 Mar; 297(12):1319-31. PubMed ID: 17384437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry.
    Kociol RD; Greiner MA; Hammill BG; Eapen ZJ; Fonarow GC; Klaskala W; Mills RM; Curtis LH; Hernandez AF
    Am Heart J; 2012 Jun; 163(6):994-1001. PubMed ID: 22709752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
    Maeder MT; Kaye DM
    Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
    Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
    J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia.
    Madan VD; Novak E; Rich MW
    Circ Heart Fail; 2011 Sep; 4(5):637-43. PubMed ID: 21673193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).
    Vaduganathan M; Greene SJ; Ambrosy AP; Mentz RJ; Fonarow GC; Zannad F; Maggioni AP; Konstam MA; Subacius HP; Nodari S; Butler J; Gheorghiade M;
    Am J Cardiol; 2013 Dec; 112(11):1763-9. PubMed ID: 24095030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.
    Mentz RJ; Greene SJ; Ambrosy AP; Vaduganathan M; Subacius HP; Swedberg K; Maggioni AP; Nodari S; Ponikowski P; Anker SD; Butler J; Gheorghiade M
    Circ Heart Fail; 2014 May; 7(3):401-8. PubMed ID: 24737459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
    Greene SJ; Gheorghiade M; Vaduganathan M; Ambrosy AP; Mentz RJ; Subacius H; Maggioni AP; Nodari S; Konstam MA; Butler J; Filippatos G;
    Eur J Heart Fail; 2013 Dec; 15(12):1401-11. PubMed ID: 23845795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
    Ambrosy AP; Pang PS; Khan S; Konstam MA; Fonarow GC; Traver B; Maggioni AP; Cook T; Swedberg K; Burnett JC; Grinfeld L; Udelson JE; Zannad F; Gheorghiade M;
    Eur Heart J; 2013 Mar; 34(11):835-43. PubMed ID: 23293303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
    Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
    Butler J; Subacius H; Vaduganathan M; Fonarow GC; Ambrosy AP; Konstam MA; Maggioni A; Mentz RJ; Swedberg K; Zannad F; Gheorghiade M;
    J Am Coll Cardiol; 2013 Feb; 61(5):571-9. PubMed ID: 23246389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.